Current:Home > MarketsTwo sets of US rowers qualify for finals as lightweight pairs falls off -FinanceCore
Two sets of US rowers qualify for finals as lightweight pairs falls off
Indexbit View
Date:2025-04-09 20:45:31
VAIRES-SUR-MARNE, France – Team USA rowers Michelle Sechser and Molly Reckford finished third in their Olympic semifinal heat of the lightweight women’s doubles sculls Wednesday to advance to Friday’s finals at Vaires-sur-Marne Nautical Stadium.
Sechser and Reckford qualified in a time of 7:05.03, behind rowing power Great Britain (6:59.79) and New Zealand (7:02.86).
Sechser and Reckford finished fifth, a second behind the gold-medal winning Italian team, at the 2020 Olympic Games.
"I'm obviously biased I think it's the best race that's ever happened in the sport of rowing," Reckford said of the 2020 Olympic final. "But like many of the same crews who have again qualified for the final, that was a wild experience and like I said I've dreamt about having another chance at that race since then."
Ireland, Greece and Romania will join the U.S., Great Britain and New Zealand in the final.
2024 Olympic medals: Who is leading the medal count? Follow along as we track the medals for every sport.
This is the last year for lightweight pairs at the Olympics as the event will be replaced by coastal rowing at the Los Angeles Games in 2028 as part of a push by the International Olympic Committee to do away with weight-class division in non-combat sports.
Jess Thoennes and Azja Czajkowski, the U.S. women's rowing pair also qualified for the finals in their event Friday with a second-place finish behind Australia. Lithuania, Netherlands, Romania and Greece also reached the finals.
"Full transparency, I was a little surprised to look over and see that we were up after 500, but it was good," Czajkowski said. "I think we just did our thing and it was epic that the heat, we shook some of the sillies out and now we're in a good spot, I think."
veryGood! (7)
Related
- Why we love Bear Pond Books, a ski town bookstore with a French bulldog 'Staff Pup'
- Pennsylvania Grand Jury Faults State Officials for Lax Fracking Oversight
- NYC could lose 10,000 Airbnb listings because of new short-term rental regulations
- Connecticut Passed an Environmental Justice Law 12 Years Ago, but Not That Much Has Changed
- 'As foretold in the prophecy': Elon Musk and internet react as Tesla stock hits $420 all
- Activists Call for Delay to UN Climate Summit, Blaming UK for Vaccine Delays
- Fox News' Sean Hannity says he knew all along Trump lost the election
- Kelly Ripa Details the Lengths She and Mark Consuelos Go to For Alone Time
- Megan Fox's ex Brian Austin Green tells Machine Gun Kelly to 'grow up'
- Rudy Giuliani should be disbarred for false election fraud claims, D.C. review panel says
Ranking
- Toyota to invest $922 million to build a new paint facility at its Kentucky complex
- Kelly Ripa Details the Lengths She and Mark Consuelos Go to For Alone Time
- Besieged by Protesters Demanding Racial Justice, Trump Signs Order Waiving Environmental Safeguards
- You People Don't Want to Miss New Parents Jonah Hill and Olivia Millar's Sweet PDA Moment
- Senate begins final push to expand Social Security benefits for millions of people
- The Biomass Industry Expands Across the South, Thanks in Part to UK Subsidies. Critics Say it’s Not ‘Carbon Neutral’
- Brian Austin Green Slams Bad Father Label After Defending Megan Fox
- Mary-Louise Parker Addresses Ex Billy Crudup's Marriage to Naomi Watts
Recommendation
$73.5M beach replenishment project starts in January at Jersey Shore
Full transcript of Face the Nation, July 9, 2023
From Twitter chaos to TikTok bans to the metaverse, social media had a rocky 2022
California's governor won't appeal parole of Charles Manson follower Leslie Van Houten
Global Warming Set the Stage for Los Angeles Fires
John Mellencamp Admits He Was a S--tty Boyfriend to Meg Ryan Nearly 4 Years After Breakup
Global Carbon Emissions Unlikely to Peak Before 2040, IEA’s Energy Outlook Warns
CVS and Walgreens limit sales of children's meds as the 'tripledemic' drives demand